The global Inhaled Nitric Oxide market size was valued at USD 650 Million in 2021 growing at the CAGR of 9.1% from 2022 to 2032. Nitric oxide is a gas that is inhaled through the nose or mouth to relax smooth muscles and widen blood vessels in the lungs. It is used in newborn babies who are experiencing respiratory failure caused by pulmonary hypertension, in conjunction with a ventilator and other agents.
- Increase in the prevalence of diseases in the newborn such as persistent pulmonary hypertension, and neonatal hypoxic respiratory failure (HRF)
The major factor driving the growth of the Inhaled Nitric Oxide market is the increase in the prevalence of diseases in newborns such as persistent pulmonary hypertension. The number of babies born with this disease has been on the rise in recent years, and inhaled nitric oxide is an effective treatment. Inhaled nitric oxide is also being used more frequently to treat other conditions such as bronchopulmonary dysplasia and respiratory distress syndrome. With the increasing prevalence of these conditions, the demand for inhaled nitric oxide is expected to continue to grow.
Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=newsmantraa&reportCode=016678
Key Highlights:
- The global Inhaled Nitric Oxide market size was valued at USD 650 Million in 2021 growing at the CAGR of 9.1% from 2022 to 2032.
- North America dominated the market in 2021
- Asia Pacific is expected to grow at a highest CAGR from 2022 to 2032
Key Players
The Inhaled Nitric Oxide market report gives comprehensive information about the company and its past performance. The report also provide a detail market share analysis along with product benchmarking with key developments.
The key players profiled in the report are:
- AIR LIQUIDE S.A.
- BELLEROPHON THERAPEUTICS, INC.
- BOC HEALTHCARE
- BEYOND AIR, INC.
- HALMA PLC
- LINDE PLC (PRAXAIR, INC.)
- MALLINCKRODT PLC
- NOVOTERIS, LLC
- VERO BIOTECH LLC
- NU-MED PLUS
The Global Inhaled Nitric Oxide Logistic report also includes information on company profiles, product descriptions, revenue, market share data, and contact details for several regional, global, and local companies. Due to increased technological innovation, R&D, and M&A operations in the sector, the market is becoming more popular in particular niche sectors. Additionally, a large number of regional and local vendors in the Inhaled Nitric Oxide market provide specialised product offerings according to geographical regions in keeping with the global manufacturing footprint. Due to the reliability, quality, and technological modernity of the worldwide suppliers, it is difficult for the new market entrants to compete.
COVID Impact
In terms of COVID 19 impact, the Inhaled Nitric Oxide market report also includes the following data points:
- COVID19 Impact on Inhaled Nitric Oxide market size
- End-User/Industry/Application Trend, and Preferences
- Government Policies/Regulatory Framework
- Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
- Opportunity in the Inhaled Nitric Oxide market
Get a Free Sample Copy of This Report @ https://report.evolvebi.com/index.php/sample/request?referer=newsmantraa&reportCode=016678
Scope of the Report:
Market Segment By Application:
- Neonatal Respiratory Treatment
- Chronic Obstructive Pulmonary Disease (COPD)
- Acute Respiratory Distress Syndrome (ARDS)
- Others
For more information: https://report.evolvebi.com/index.php/sample/request?referer=newsmantraa&reportCode=016678
Key Region/ Countries Covered
- North America (US, Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of MEA)
- Latin America (Mexico, Brazil, Argentina, Rest of Latin America)
The Asia-Pacific region is expected to grow in this market due to the number of highest live births per 1000 people, as well as the rise in the prevalence of respiratory distress syndrome and hypoxic respiratory failure associated with persistent pulmonary hypertension of the newborn (PPHN).
Reasons to Buy this Report:
- Detail analysis of the impact of market drivers, restraints, and oppotunities
- Competitive Intelligence providing the understanding about the ecosystem
- Details analysis of Total Addressable Market (TAM) of your products
- Investment Pockets and New Business Opportunities
- Demand-supply gap analysis
- Strategy Planning
About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging the pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune’s global 2000 companies.
Contact Us:
Evolve Business Intelligence
India
Contact: +1 773 644 5507 (US) / +441163182335 (UK)
Email: sales@evolvebi.com
Website: www.evolvebi.com
